Pharmaco - Articles
04-Apr-2022
15 Pharma and Life Science events taking place in April 2022, including events in Gene Therapy, Process Development, Medical Affairs, Translational Medicine, Clinical Project Management, Drug Development and more.
15 Pharma and Life Science events taking place in April 2022, including events in Gene Therapy, Process Development, Medical Affairs, Translational Medicine, Clinical Project Management, Drug Development and more. 2nd Gene Therapy for Muscular Disorders Summit (April 4th-7th) The summit will be returning as an in-person event to Boston in April 2022, to help gene therapy developers targeting muscular disorders to overcome safety and toxicity challenges and effectively translate their programs into the clinic. LNP Formulation and Process Development Summit 2022 (April 12th-14th) Th…
15 Pharma and Life Science events taking place in April 2022, including events in Gene Therapy, Process Development, Medical Affairs, Translational Medicine, Clinical Project Management, Drug Development and more. 2nd Gene Therapy for Muscular Disorders Summit (April 4th-7th) The summit will be returning as an in-person event to Boston in April 2022, to help gene therapy developers targeting muscular disorders to overcome safety and toxicity challenges and effectively translate their programs into the clinic. LNP Formulation and Process Development Summit 2022 (April 12th-14th) Th…
Pearl Chemist Group Director and Superintendent Pharmacist, Mayank Patel, is ahead of the curve when it comes to implementing the new pharmacy hub and spoke model. Here he talks about how investing in technology early has allowed him to grow his business and build better relationships with patients.
“It’s no secret that as pharmacists we are navigating a new and more demanding healthcare landscape. Our role has changed significantly since the start of the 21st century due to increased expectations from the public, advances in science and technology and changing workforce pressures. The Community Pharmacy Contractual Framework for England has placed a higher focus on clinical service. In addition, the Covid-19 pandemic resulted in significant acceleration in changing how we work day-to-day a…
“It’s no secret that as pharmacists we are navigating a new and more demanding healthcare landscape. Our role has changed significantly since the start of the 21st century due to increased expectations from the public, advances in science and technology and changing workforce pressures. The Community Pharmacy Contractual Framework for England has placed a higher focus on clinical service. In addition, the Covid-19 pandemic resulted in significant acceleration in changing how we work day-to-day a…
Molecular docking technology remains the most popular structure-based drug design method, which takes full advantage of protein-ligand interaction information. However, in virtual screening, compared with molecular docking, pharmacophore-based methods have obvious advantages in terms of computational cost and accuracy, and docking-based virtual screening methods show a higher false positive rate.
Structure-based Pharmacophore Molecular docking technology remains the most popular structure-based drug design method, which takes full advantage of protein-ligand interaction information. However, in virtual screening, compared with molecular docking, pharmacophore-based methods have obvious advantages in terms of computational cost and accuracy, and docking-based virtual screening methods show a…
Structure-based Pharmacophore Molecular docking technology remains the most popular structure-based drug design method, which takes full advantage of protein-ligand interaction information. However, in virtual screening, compared with molecular docking, pharmacophore-based methods have obvious advantages in terms of computational cost and accuracy, and docking-based virtual screening methods show a…
The pace at which pharmaceutical manufacturers have embraced digitalisation has accelerated over the past two years with many adopting Pharma 4.0 principles in line with the urgent need to drive speed to market and be ready for demand spikes through the pandemic and beyond.
The pace at which pharmaceutical manufacturers have embraced digitalisation has accelerated over the past two years with many adopting Pharma 4.0 principles in line with the urgent need to drive speed to market and be ready for demand spikes through the pandemic and beyond. The rate at which Covid-19 vaccines were developed and manufactured has been impressive thanks to the innovative ways pharmaceutical enterprises and medical bodies, across private and public sectors, have been able to work together. The sector, which…
The pace at which pharmaceutical manufacturers have embraced digitalisation has accelerated over the past two years with many adopting Pharma 4.0 principles in line with the urgent need to drive speed to market and be ready for demand spikes through the pandemic and beyond. The rate at which Covid-19 vaccines were developed and manufactured has been impressive thanks to the innovative ways pharmaceutical enterprises and medical bodies, across private and public sectors, have been able to work together. The sector, which…
17-Mar-2022
In response to the pandemic, regulators accepted virtual audit inspections. Two years on, is remote auditing here to stay? Alasdair Leckie, Operations Manager at Rephine Ltd, reveals the findings of research among international pharma clients and senior auditors looking to the future of auditing.
Before the pandemic, the pharma industry and its regulators would not have entertained the concept of remote audits to verify that the manufacturing and distribution standards of supply-chain partners were being maintained. Even the suppliers themselves would not have expected to be monitored at distance. The last two years have changed that, as lockdowns, social distancing and travel restrictions disrupted normal conditions. Rather than curtail audits altogether, with potential risk to product qua…
Before the pandemic, the pharma industry and its regulators would not have entertained the concept of remote audits to verify that the manufacturing and distribution standards of supply-chain partners were being maintained. Even the suppliers themselves would not have expected to be monitored at distance. The last two years have changed that, as lockdowns, social distancing and travel restrictions disrupted normal conditions. Rather than curtail audits altogether, with potential risk to product qua…
01-Apr-2022
15 Pharma and Life Science events taking place in March 2022, including events on drug development, gene therapy, drug safety, regulatory affairs, pharma supply chains, digitalisation and transformation, and more.
15 Pharma and Life Science events taking place in March 2022: 2nd Interstitial Lung Disease Drug Development Summit (March 7th-9th) The timely 2nd ILD Summit will siphon critical insights from experts at Pfizer, Genentech, Novartis, Boehringer Ingelheim and Pieris Pharmaceuticals to help you catalyze a new wave of therapies against Scleroderma, Sarcoidosis, COP, CT-ILDs and more. Gene Therapy for Rare Disorders 2022 (March 7th-10th) As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, G…
15 Pharma and Life Science events taking place in March 2022: 2nd Interstitial Lung Disease Drug Development Summit (March 7th-9th) The timely 2nd ILD Summit will siphon critical insights from experts at Pfizer, Genentech, Novartis, Boehringer Ingelheim and Pieris Pharmaceuticals to help you catalyze a new wave of therapies against Scleroderma, Sarcoidosis, COP, CT-ILDs and more. Gene Therapy for Rare Disorders 2022 (March 7th-10th) As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, G…
The move to digitalisation and the migration to the cloud have been happening gradually within the pharmaceutical sector. Immature digital cultures, lack of in-house data skills, or poorly defined digital strategies have combined to hold businesses back and historically, misperceptions of the cloud have played into this. Manufacturers that have established legacy systems are often unduly concerned about the security risks of moving to the cloud.
The move to digitalisation and the migration to the cloud have been happening gradually within the pharmaceutical sector. Immature digital cultures, lack of in-house data skills, or poorly defined digital strategies have combined to hold businesses back and historically, misperceptions of the cloud have played into this. Manufacturers that have e…
The move to digitalisation and the migration to the cloud have been happening gradually within the pharmaceutical sector. Immature digital cultures, lack of in-house data skills, or poorly defined digital strategies have combined to hold businesses back and historically, misperceptions of the cloud have played into this. Manufacturers that have e…
Jonas Lundqvist, CEO at Haidrun, explains how blockchain can help eliminate fraud and make a substantive difference to the pharmaceutical supply chain.
Pharmaceutical fraud remains a major challenge for the healthcare industry and the coronavirus pandemic has led to a further rise in counterfeit medicines creating a serious health threat to patients and significant challenges for enforcement authorities. From a supply chain perspective, it diminishes the commercial trust that needs to exist between organisations to provide essential products from manufacturing to patient. In the US alone, according to Deloitte, more than $200bn is lost each year because of counterfeit drugs infiltrating insecure supply chains. Against this backdrop, blockchain has been identified by the pharmaceutical indus…
Pharmaceutical fraud remains a major challenge for the healthcare industry and the coronavirus pandemic has led to a further rise in counterfeit medicines creating a serious health threat to patients and significant challenges for enforcement authorities. From a supply chain perspective, it diminishes the commercial trust that needs to exist between organisations to provide essential products from manufacturing to patient. In the US alone, according to Deloitte, more than $200bn is lost each year because of counterfeit drugs infiltrating insecure supply chains. Against this backdrop, blockchain has been identified by the pharmaceutical indus…
A unique tension for life science companies is emerging between the opening of borders driven by flexible working post-pandemic and, simultaneously, restrictions on the flow of talent between key hubs such as Switzerland and the UK post-Brexit. In a fiercely competitive market, how can life science companies battle these opposing forces, and in particular, how does this affect recruitment of top in-house legal talent?
A unique tension for life science companies is emerging between the opening of borders driven by flexible working post-pandemic and, simultaneously, restrictions on the flow of talent between key hubs such as Switzerland and the UK post-Brexit. In a fiercely competitive market, how can life science companies battle these opposing forces, and in particular, how does this affect…
A unique tension for life science companies is emerging between the opening of borders driven by flexible working post-pandemic and, simultaneously, restrictions on the flow of talent between key hubs such as Switzerland and the UK post-Brexit. In a fiercely competitive market, how can life science companies battle these opposing forces, and in particular, how does this affect…
Top Pharma and Life Science events taking place in February 2022, including events in Pharmacovigilance, Drug Discovery, Vaccine Development, Drug Development, RNA Therapeutics and more.
Top Pharma and Life Science events taking place in February 2022: Fierce Drug Safety Summit (February 8th-9th) The Fierce Drug Safety Summit will allow large, medium, and small-sized pharma, biotechs and device companies to learn how to better perform their drug safety processes. Attendees will learn best practices and be better equipped to meet government regulations, ensuring the safety of their patients. RNA Therapeutics 2022 (February 9th-10th) The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing v…
Top Pharma and Life Science events taking place in February 2022: Fierce Drug Safety Summit (February 8th-9th) The Fierce Drug Safety Summit will allow large, medium, and small-sized pharma, biotechs and device companies to learn how to better perform their drug safety processes. Attendees will learn best practices and be better equipped to meet government regulations, ensuring the safety of their patients. RNA Therapeutics 2022 (February 9th-10th) The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing v…
21-Jan-2022
What are the influences on Quality Management today? And what does the future hold for Quality in the era of smart automation? Late last year, James Kelleher, CEO of Generis, chaired a discussion of experts from Merck, Syneos Health and Accenture.
What are the influences on Quality Management today? And what does the future hold for Quality in the era of smart automation? Late last year, James Kelleher, CEO of Generis, chaired a discussion of experts from Merck, Syneos Health and Accenture. Taking part were: Dr. Heiner Niessen, Head of Application Technology Quality & Compliance at Merck Peter Brandstetter, Quality and Regulatory expert at Accenture James Man, Quality subject expert and R&D Advisory Managing Director at Syneos Health. Here are the edited highlights. Is the era of…
What are the influences on Quality Management today? And what does the future hold for Quality in the era of smart automation? Late last year, James Kelleher, CEO of Generis, chaired a discussion of experts from Merck, Syneos Health and Accenture. Taking part were: Dr. Heiner Niessen, Head of Application Technology Quality & Compliance at Merck Peter Brandstetter, Quality and Regulatory expert at Accenture James Man, Quality subject expert and R&D Advisory Managing Director at Syneos Health. Here are the edited highlights. Is the era of…
The following discussion is based on the requirements described in the EU Guideline on Good Distribution Practice of medicinal products for human use, however, the GDP Guidelines for active substances, the GMP Guidelines and similar regulations contain comparable requirements for the respective areas within or outside of the EU.
Legal and regulatory requirements, including GMP and GDP guidelines, require consistently that medicinal products shall be stored and transported in a way that the product delivered maintain their quality and integrity and remain within the legal supply chain during storage and/or transportation. Storage and transport need to be described in the Pharmaceutical Quality System and the principles of quality risk management shall be used for designing and managing these…
Legal and regulatory requirements, including GMP and GDP guidelines, require consistently that medicinal products shall be stored and transported in a way that the product delivered maintain their quality and integrity and remain within the legal supply chain during storage and/or transportation. Storage and transport need to be described in the Pharmaceutical Quality System and the principles of quality risk management shall be used for designing and managing these…
04-Jan-2022
The life sciences industry has evolved tremendously with the acceleration of technology, and digital development presents many opportunities for research and overall process improvements. As we continue to innovate and imagine the future, our annual summit Breakthrough was an insightful look into the technology and upcoming trends of life sciences.
The life sciences industry has evolved tremendously with the acceleration of technology, and digital development presents many opportunities for research and overall process improvements. As we continue to innovate and imagine the future, our annual summit Breakthrough was an insightful look into the technology and upcoming trends of life sciences. Over two days, leaders from established pharma and emerging biotechs discussed the outlook fo…
The life sciences industry has evolved tremendously with the acceleration of technology, and digital development presents many opportunities for research and overall process improvements. As we continue to innovate and imagine the future, our annual summit Breakthrough was an insightful look into the technology and upcoming trends of life sciences. Over two days, leaders from established pharma and emerging biotechs discussed the outlook fo…
As drug and medical device production ramped up to respond to the pandemic, manufacturers faced the challenge of more effectively monitoring, analysing, reporting and acting on quality performance. Siniša Belina, senior life sciences consultant at Amplexor, reveals the latest best practice.
Across a whole swathe of industries the Covid-19 pandemic has shone a light on restrictive business processes, information silos and poor supply-chain visibility. In life sciences manufacturing, for instance, a range of challenges linked to quality management have been exposed and starkly felt. On the one hand, public safety measures over the last 18+ months have put physical distance between team members - hampering the usual form-filling, manual sign-offs and Excel-based record-keeping associated with…
Across a whole swathe of industries the Covid-19 pandemic has shone a light on restrictive business processes, information silos and poor supply-chain visibility. In life sciences manufacturing, for instance, a range of challenges linked to quality management have been exposed and starkly felt. On the one hand, public safety measures over the last 18+ months have put physical distance between team members - hampering the usual form-filling, manual sign-offs and Excel-based record-keeping associated with…
The pharma industry is continuously striving to be more customer-led in its activities, but the healthcare ecosystem is complex, meaning that product teams must consider the relative needs of a whole range of stakeholders. Here, drawing on new research, Malte Scholz of airfocus discusses what’s needed today to navigate and balance those differing priorities.
For all that pharma organisations claim to have refocused their efforts around customers over the last decade or more, mapping new developments to tangible outcomes isn’t easy. In pharma, this challenge is particularly acute due to the diversity of stakeholders with views on what they want from next-generation products. In addition to the ultimate customers (patients), physicians, speciality clinicians, regulators, payers and insurers a…
For all that pharma organisations claim to have refocused their efforts around customers over the last decade or more, mapping new developments to tangible outcomes isn’t easy. In pharma, this challenge is particularly acute due to the diversity of stakeholders with views on what they want from next-generation products. In addition to the ultimate customers (patients), physicians, speciality clinicians, regulators, payers and insurers a…
In this article, we’ve put together a list of the best Life Sciences organisations to work for in the UK, using the official rankings given by The Great Place to Work Institute in 2021.
In this article, we’ve put together a list of the best Life Sciences organisations to work for in the UK, using the official rankings given by The Great Place to Work Institute in 2021… Small Workplaces (20-50 Employees) Chugai Pharma Europe Chugai Pharma Europe employs more than 250 experts across eight European countries, including in London, UK, where around 46 employees work. This pharmaceutical organisation ranked 17th in the UK’s Best Small Workplaces list. 97% of employees are proud to tell others they work for the organisation, with 95% agreeing that management is honest and ethical in its business p…
In this article, we’ve put together a list of the best Life Sciences organisations to work for in the UK, using the official rankings given by The Great Place to Work Institute in 2021… Small Workplaces (20-50 Employees) Chugai Pharma Europe Chugai Pharma Europe employs more than 250 experts across eight European countries, including in London, UK, where around 46 employees work. This pharmaceutical organisation ranked 17th in the UK’s Best Small Workplaces list. 97% of employees are proud to tell others they work for the organisation, with 95% agreeing that management is honest and ethical in its business p…
For the first time, companies are prioritising quality over cost for pharmacovigilance automation. John Price, life sciences industry consultant and advisor to Arriello, which commissioned this latest research, presents the findings of a brand new transatlantic survey into the industry’s PV automation intentions.
Although the COVID-19 pandemic has stalled progress with digital process transformation, many life sciences companies’ ambitions to apply smart solutions to rising pharmacovigilance workloads remain central to the investment agenda. These are the findings of Arriello’s second annual transatlantic survey of 200 professionals in senior roles spanning PV, Drug Safety and Product Safety departments. This year, quality overtook cost to become the primary criterion for automating PV work…
Although the COVID-19 pandemic has stalled progress with digital process transformation, many life sciences companies’ ambitions to apply smart solutions to rising pharmacovigilance workloads remain central to the investment agenda. These are the findings of Arriello’s second annual transatlantic survey of 200 professionals in senior roles spanning PV, Drug Safety and Product Safety departments. This year, quality overtook cost to become the primary criterion for automating PV work…
In this article, we look at nine of the top pharmaceutical companies with headquarters in the United States.
In this article, we look at nine of the top pharmaceutical companies with headquarters in the United States… Merck & Co. Founded over 130 years ago, Merck’s mission is to be the premier research-intensive biopharmaceutical company in the world. They are focused on bringing forward treatments for the world’s most challenging diseases to save and improve lives. Headquartered in New Jersey, Merck has more than 74,000 employees and in 2020 reported worldwide sales of $48 billion. Johnson & Johnson Also founded over 130 years ago, Johnson & Johnson is the world’s largest healthcare company, striving to improve access and affordability and create healthier communities for all.…
In this article, we look at nine of the top pharmaceutical companies with headquarters in the United States… Merck & Co. Founded over 130 years ago, Merck’s mission is to be the premier research-intensive biopharmaceutical company in the world. They are focused on bringing forward treatments for the world’s most challenging diseases to save and improve lives. Headquartered in New Jersey, Merck has more than 74,000 employees and in 2020 reported worldwide sales of $48 billion. Johnson & Johnson Also founded over 130 years ago, Johnson & Johnson is the world’s largest healthcare company, striving to improve access and affordability and create healthier communities for all.…
28-Jan-2022
9 pharmaceutical events taking place in October 2021, including BioFuture Conference, Pharma 2021, Project Management for Clinical Trials and Advanced Process in Pharma.
9 pharmaceutical events taking place in October 2021: BioFuture™ Conference (October 5th-6th) BioFuture is a conference convening future-focused healthcare thinkers, top investors, stakeholders and cutting-edge companies to “Reimagine the Future of Healthcare.” It will be held in New York City at Cure, Deerfield’s vertical healthcare-dedicated innovation campus, with a virtual attendance option. SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom (October 6th-7th) This one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals, biologicals, and cleanroom i…
9 pharmaceutical events taking place in October 2021: BioFuture™ Conference (October 5th-6th) BioFuture is a conference convening future-focused healthcare thinkers, top investors, stakeholders and cutting-edge companies to “Reimagine the Future of Healthcare.” It will be held in New York City at Cure, Deerfield’s vertical healthcare-dedicated innovation campus, with a virtual attendance option. SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom (October 6th-7th) This one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals, biologicals, and cleanroom i…
08-Oct-2021
13 pharmaceutical events taking place in September 2021, including: Euro-Global Conference on Biotechnology and Bioengineering (September 6th-8th), 4th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems (September 6th-8th), 2nd Operationalize: Decentralized Clinical Trials Summit (September 7th-9th) and more.
13 pharmaceutical events taking place in September 2021: Euro-Global Conference on Biotechnology and Bioengineering (September 6th-8th) The theme of this conference is ‘Addressing Current Challenges in Biotechnology and Bioengineering.’ ECBB 2021 will consist of keynote lectures, oral & poster presentations, workshops, and seminars from experts and young scholars in the field of Biotechnology and Bioengineering. 4th Edition of Global Conference on Pharmac…
13 pharmaceutical events taking place in September 2021: Euro-Global Conference on Biotechnology and Bioengineering (September 6th-8th) The theme of this conference is ‘Addressing Current Challenges in Biotechnology and Bioengineering.’ ECBB 2021 will consist of keynote lectures, oral & poster presentations, workshops, and seminars from experts and young scholars in the field of Biotechnology and Bioengineering. 4th Edition of Global Conference on Pharmac…
